相关实验视频
Updated: Jul 13, 2025
00:07
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
7.3K
MiR-484通过抑制CDKN2A表达来促进质瘤的恶性进展
Yingrui Gu1, Hongbing Lei1, Peipei Ma1
1Department of Neurosurgery, The First Affiliated Hospital of China Naval Medical University, Shanghai, China.
Folia neuropathologica
|October 11, 2023
概括
微RNA-484 (miR-484) 通过抑制循环林依赖激酶抑制剂2A (CDKN2A) 表达,促进质瘤细胞迁移和入侵. 这项研究揭示了质瘤进展中的新型分子机制.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 循环林依赖激酶抑制剂2A (CDKN2A) 在质瘤进展中的作用已经确立,但其精确的影响细胞迁移和侵入的分子机制需要进一步阐明.
- 质瘤是一种普遍存在的原发性脑瘤,表现出复杂的分子变化,驱动其侵略性行为,包括增强的细胞运动性和组织透.
研究的目的:
- 调查CDKN2A影响质瘤细胞迁移和入侵的分子机制.
- 在质瘤的背景下探索miR-484和CDKN2A之间的调节关系.
主要方法:
- 使用癌症基因组图谱 (TCGA) 数据分析CDKN2A表达及其与质瘤患者存活率的相关性.
- 定量逆转录聚合酶连锁反应 (qRT-PCR) 和西方抹黑试验,以评估基因和蛋白质表达水平.
- 试验室试验包括伤口愈合,Transwell和管形成试验,以评估细胞迁移,入侵和血管生成.
- 双 luciferase 记者基因测定以确认 miR-484 和 CDKN2A 之间的直接结合.
主要成果:
- CDKN2A在质瘤组织和细胞中表达较低,与患者预后不佳相关.
- 发现CDKN2A的下调促进了质瘤细胞的迁移,入侵和血管生成.
- miR-484在质瘤细胞上调,其上调增强了细胞迁移,入侵和血管生成.
- miR-484对CDKN2A的表达进行了负调节,CDKN2A部分抵消了miR-484的前迁移性和侵入性作用.
结论:
- MiR-484通过抑制CDKN2A表达促进质瘤细胞迁移,入侵和血管生成.
- miR-484/CDKN2A轴代表了管理质瘤进展的潜在治疗点.
相关概念视频
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
01:20The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
01:22MicroRNAs
21.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.3K
01:22PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K